Randomised clinical trial: certolizumab pegol for fistulas in Crohn's disease - subgroup results from a placebo-controlled study

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	185-193
Journal	Alimentary pharmacology & therapeutics
Volume	33
DOIs	https://doi.org/10.1111/j.1365-2036.2010.04509.x
Publication status	Published - 2011

Access to Document

@article{8a6959c0cc5b45ddab6d03393de1f853,

title = "Randomised clinical trial: certolizumab pegol for fistulas in Crohn's disease - subgroup results from a placebo-controlled study",

author = "S. Schreiber and Ian Lawrance and O.{\O}. Thomsen and S.B. Hanauer and R. Bloomfield and W.J. Sandborn",

year = "2011",

doi = "10.1111/j.1365-2036.2010.04509.x",

language = "English",

volume = "33",

pages = "185--193",

journal = "Alimentary pharmacology \& therapeutics",

issn = "0269-2813",

publisher = "John Wiley \& Sons",

}

TY - JOUR

T1 - Randomised clinical trial: certolizumab pegol for fistulas in Crohn's disease - subgroup results from a placebo-controlled study

AU - Schreiber, S.

AU - Lawrance, Ian

AU - Thomsen, O.Ø.

AU - Hanauer, S.B.

AU - Bloomfield, R.

AU - Sandborn, W.J.

PY - 2011

Y1 - 2011

U2 - 10.1111/j.1365-2036.2010.04509.x

DO - 10.1111/j.1365-2036.2010.04509.x

M3 - Article

SN - 0269-2813

VL - 33

SP - 185

EP - 193

JO - Alimentary pharmacology & therapeutics

JF - Alimentary pharmacology & therapeutics

ER -